Dual inhibition of Aurora kinase A and JAK2 reduces graft-versus-host-disease, preserves the ability of the immune system to fight infections and tumor cells. Graft-versus-host-disease (GVHD) is the leading cause of non-relapse associated death in patients who receive stem cell transplants. In a new study published as the cover story in Science Translational Medicine, Moffitt Cancer...